Results 51 to 60 of about 3,148,135 (237)
Abstract Janus kinase inhibitors (JAKi) are increasingly used for refractory inflammatory bowel disease (IBD) in pediatric patients but are associated with significant dermatologic adverse effects. Acneiform eruptions have been reported in up to 30% of adults, with a greater incidence suspected in adolescents.
Tina H. Tran +5 more
wiley +1 more source
Background: Generalized bullous fixed drug eruption (GBFDE), a particular form of fixed drug eruption (FDE), is characterized by widespread blisters and erosions and can be confused with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
朱家瑜 +1 more
core +1 more source
Nail Toxicities Associated With Anticancer Therapies in Children
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley +1 more source
Molar incisor hypomineralisation: current knowledge and practice
Background Molar incisor hypomineralisation (MIH) is a common developmental dental condition that presents in childhood. Areas of poorly formed enamel affect one or more first permanent molars and can cause opacities on the anterior teeth. MIH presents a variety of challenges for the dental team as well as functional and social impacts for affected ...
Helen D. Rodd +4 more
wiley +1 more source
Oral mucosal fixed drug eruption: Characteristics and differential diagnosis
Background: Little is known about the characteristic features of oral mucosal fixed drug eruption (FDE)
Ozkaya, Esen
core +1 more source
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva +17 more
wiley +1 more source
Generalized Bullous Fixed Drug Eruption due to Bromhexine [PDF]
We describe a patient with a generalized bullous form of Fixed Drug Eruption (FDE) induced by bromhexine, a commonly used drug for respiratory symptoms. This is a rare association and generalized bullous FDE is also very rare. We emphasize the importance
Cunha, A. P. +12 more
core +1 more source
Fixed Solar Eruption: A Case Report
ABSTRACT Fixed eruption is characterized by recurrent lesions at identical anatomical sites after exposure to a trigger. Although most cases are drug‐induced, ultraviolet (UV) radiation has also been reported as a causative factor. We report a case of fixed solar eruption diagnosed by histopathology and 308 nm excimer light phototesting.
Yukiko Tateno +3 more
wiley +1 more source
Levofloxacin-induced fixed drug eruption
Fixed drug eruption is a distinctive cutaneous adverse drug reaction characterised by the recurrence of well-demarcated lesions at the same anatomical site following re-exposure to the offending drug, with residual hyperpigmentation after resolution ...
Malay Jayantigiri Goswami +3 more
core +1 more source
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman +5 more
wiley +1 more source

